
A blood test has been created that could offer an inexpensive, and less invasive, alternative to current Alzheimer’s disease tests. …

The European Commission has announced that it has decided to approve Leo Pharma’s Kyntheum (brodalumab), making it the first and …

Daniel Ray, Head of NHS Digital discusses the importance of data usage in the healthcare system and the NHS Digital …

Sanofi is steadily recovering from missing out on Actelion to J&J by making another deal, this time with Ablynx biotech …

NICE has reached a decision in its final appraisal determination of Teva’s Cinqaero (reslizumab), recommending the drug’s use as an …

A three year report by the Care Quality Commission (CQC) has found that though compassionate care is being offered broadly …

GSK’s Emma Walmsley looks set to begin her rejig of the business, as she aims to offload part of its …

An independent steering committee has compiled a report looking at how more can be delivered from the NHS budget, without …

A collaboration between Swiss antibody therapeutics firm Humab BioMed and the University of California, Berkeley has given rise to an …

The FDA has announced that it has chosen to approve Vosevi (sofosbuvir/velpatasvir/voxilaprevir), Gilead’s investigational drug for the treatment of chronic …

Researchers at the Perelman School of Medicine at the University of Pennsylvania have found that by combining specific hormone-based drugs …

According to a new report commissioned by the ABPI, the UK is continuing to fall behind in the diagnosis and …

Jesper Høiland has been revealed as the new President and Chief Executive Officer of Radius. The news comes shortly after …

Novartis has reiterated its expectation of sales growth beginning in 2018, as well as a positive outlook for its Alcon …

Puma Biotech has pounced to secure FDA approval for its extended adjuvant treatment for early-stage, HER2-positive breast cancer. The drug, …